Cockayne syndrome, MEN1, and genomic variants: Exome sequencing is changing our view of the genetic landscape

Pediatr Dermatol. 2021 Jul;38(4):913-918. doi: 10.1111/pde.14655. Epub 2021 Jun 8.

Abstract

The availability of genomic sequencing for inherited diseases provides a more complete molecular basis for how an individual's genetic landscape influences clinical outcome. We describe a family where exome sequencing of a 3-year-old boy with clinical features of Cockayne syndrome (CS) confirmed the diagnosis of CS. He also had a mutation consistent with a pre-symptomatic second disease, multiple endocrine neoplasia type 1 (MEN1), each potentially affecting multiple organ systems, in addition to a poorly defined variant in fumarate hydratase (FH). Genomic sequencing may reveal coexisting pathogenic mutations and variants which complicate clinical interpretation.

Keywords: Cockayne Syndrome; DNA repair; MEN1; exome sequencing; genodermatosis.

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Cockayne Syndrome* / diagnosis
  • Cockayne Syndrome* / genetics
  • Exome / genetics
  • Exome Sequencing
  • Genomics
  • Humans
  • Male
  • Multiple Endocrine Neoplasia Type 1* / genetics
  • Mutation
  • Pedigree